ErlySign, a pioneering biotech start-up located in Nagpur, announces a significant milestone in the fight against cancer with approval from the Indian regulatory agency CDSCO for its active salivary biomarker study designed for early cancer detection
The Piramal Group, a leading Global Business Conglomerate, declared a Rs 110-crore interest in Biodeal Pharmaceuticals. The contract improvement and assembling organization will send the investment mixed by Piramal Options for working on its...
On the occasion of World Health Day 2024, CAHO (Consortium of Accredited Healthcare Organizations), a distinguished not-for-profit organization committed to advancing quality initiatives within Indian healthcare establishments, proudly announces...
Johnson and Johnson, a pharmaceutical industry firm, has declared a conclusive arrangement to acquire all outstanding Shockwave Medical, Inc. shares for $335.00 per share in real money. This transaction relates to a venture worth roughly $13.1...
India's healthcare industry scene has changed, pushed by significant interests in framework improvement. The Union Health Ministry's allotment of Rs 90,658.63 crore in the interim Budget for 2024-2025 showcases a 12.59 percent hike, highlighting...
Dr. Reddy’s Laboratories Ltd, a leading multinational pharmaceutical company, has forayed into an alliance with Bayer to promote and distribute the heart failure drug Vericiguat brand throughout India. Dr. Reddy’s...
Concept Medical, which is among the most advanced medical device technology producers, has gotten the green light to continue the clinical trial for its FDA breakthrough-approved AVF MagicTouch for stenotic lesions of Arteriovenous Fistula
HCG Cancer Center Nagpur brought out a state-of-the-art and first-of-its-kind modern scalp-cooling therapy in Asia for patients diagnosed with cancer and being treated with chemotherapy.
Jupiter Hospital is taking a bold step to inspire change and transform healthcare from impersonal to humanistic with the launch of its new "#Notjustanumber" campaign.
Naming the matter “issue of medical safetyâ€, Roche has requested DCGI, the Indian regulatory body, to investigate the alleged critical gaps in the clinical trial conducted by Zydus using the drug developed by Roche previously.
, CDSCO.jpg)
.jpg)